Ignite Creation Date:
2024-05-05 @ 10:41 PM
Last Modification Date:
2024-10-26 @ 10:22 AM
Study NCT ID:
NCT01167101
Status:
COMPLETED
Last Update Posted:
2015-09-04
First Post:
2010-07-20
Brief Title:
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection
Sponsor:
Kangdong Sacred Heart Hospital
Organization:
Kangdong Sacred Heart Hospital
Study Overview
Official Title:
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection Multicenter Randomized and Prospective Study
Status:
COMPLETED
Status Verified Date:
2015-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Treatment strategy of post endoscopic submucosal dissection ESD ulcer is not yet conclusive Rebamipide is a mucosal protective agent widely used in East Asia and has good effect on quality of ulcer healing QOUH The investigators will conduct this randomized controlled study to assess the effect of a combination therapy of rebamipide and proton pump inhibitor PPI on post ESD ulcer healing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None